Evidence map›Paper›PMID 33417206›Full record

ReviewAdvances in experimental medicine and biology2020

Peroxisome Biogenesis Disorders.

Masanori Honsho, Kanji Okumoto, Shigehiko Tamura, Yukio Fujiki

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Neurodegenerative Diseases in Children: A Comprehensive Review.International journal of molecular sciences · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. The peroxisome: an update on mysteries 3.0.Histochemistry and cell biology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Development and clinical translation ofComputational and structural biotechnology journal · 2022
    Review
  17. Article
  18. Translational pediatrics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Masanori HonshoInstitute of Rheological Functions of Food, Fukuoka, Japan.
Kanji OkumotoDepartment of Biology, Faculty of Sciences, Kyushu University Graduate School, Fukuoka, Japan.
Shigehiko TamuraFaculty of Arts and Science, Kyushu University, Fukuoka, Japan.
Yukio FujikiInstitute of Rheological Functions of Food, Fukuoka, Japan. yfujiki@kyudai.jp.
Kyushu University · JPInstitute of Rheological Functions of Food · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peroxisomes are presented in all eukaryotic cells and play essential roles in many of lipid metabolic pathways, including β-oxidation of fatty acids and synthesis of ether-linked glycerophospholipids, such as plasmalogens. Impaired peroxisome biogenesis, including defects of membrane assembly, import of peroxisomal matrix proteins, and division of peroxisome, causes peroxisome biogenesis disorders (PBDs). Fourteen complementation groups of PBDs are found, and their complementing genes termed PEXs are isolated. Several new mutations in peroxins from patients with mild PBD phenotype or patients with phenotypes unrelated to the commonly observed impairments of PBD patients are found by next-generation sequencing. Exploring a dysfunctional step(s) caused by the mutation is important for unveiling the pathogenesis of novel mutation by means of cellular and biochemical analyses.

Indexed as

Peroxisomal DisordersHumansMutationPeroxisomesPhenotypeCHO mutant cellsComplementation groups (CGs)Next-generation sequencingPeroxin gene PEXPeroxisomal biogenesis disorders (PBDs)Zellweger spectrum disorders (ZSDs)

Identifiers

PMID33417206
OpenAlexW1938284987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.